Jasper Therapeutics is trading at $0.67 (-5.48%) after renewed U.S.-Iran clashes intensified global risk-off sentiment and pushed oil prices higher.
- The broader biotech sector is also weak, with XBI down 4.24%; major indexes are lower amid inflation and interest-rate concerns.
- No new company-specific announcement was identified; the latest listed company release was dated August 14, 2026.